Enzyme, powered by the MLN token, is a digital asset management platform that strives to streamline the management of digital assets. It provides a unified, on-chain system that allows access to digital assets and DeFi from a single application. Enzyme aims to reduce operational risks associated with managing crypto and DeFi assets without purpose-built smart-contract permissions and controls. It provides a robust suite of programmable risk management and governance tools to protect assets. Enzyme also maintains sophisticated on-chain data pipelines, ensuring data is auditable and trustworthy, promoting a future based on transparency and auditability.

Enzyme operates through a system of vaults, each representing a unique portfolio with its own strategy, asset allocation, and investment goals. Users can create multiple vaults and customize each one according to their preferences. Enzyme provides tools for managing and monitoring these portfolios, including performance metrics and detailed reporting. Users can track the performance of their assets and make informed decisions about how to manage their portfolios over time. Enzyme also provides real-time reporting and performance dashboards with key performance and risk metrics, and reports that provide provable data on all transactions at any point in history.

Enzyme has a wide range of potential use cases. For instance, it can be used for treasury management, allowing organizations to manage their treasury transparently. It can also be used to set up an on-chain DeFi fund, with Enzyme taking care of all fund operations and administration using smart-contract automation. Additionally, users can build their own indexes in minutes and have them rebalance automatically on-chain or off-chain. Enzyme also allows anyone to build, scale, and monetize investment strategies using the protocol's non-custodial Vaults. These strategies can span the spectrum from traditional discretionary allocators to DeFi-native combinations of any of the primitives with which Enzyme integrates.

Enzyme, formerly known as the Melon Protocol, was initially developed by the private company Melonport. After the dissolution of Melonport, the protocol was transferred to the Enzyme Council. The protocol has been on the mainnet since February 2019 and was the first DeFi protocol to decentralize its governance. Enzyme v2, a completely re-architected protocol with modularity and extensibility at the core of its design, was launched to the mainnet in January 2021. The Enzyme token, MLN, is used to access the MLN network and incentivize developers to build on Enzyme.

We update our Enzyme to GBP currency in real-time. Get the live price of Enzyme on Coinbase.

The current market cap of Enzyme is £17.49M. A high market cap implies that the asset is highly valued by the market.

The all-time high of Enzyme is £199.67. This all-time high is highest price paid for Enzyme since it was launched.

Over the last 24 hours, the trading volume of Enzyme is £4.95M.

Assets that have a similar market cap to Enzyme include Sharp, Uranus, tao.bot, and many others. To see a full list, see our comparable market cap assets.

The current circulating supply of Enzyme is 3 million.

Enzyme ranks 209 among tradable assets on Coinbase. Popularity is currently based on relative market cap.

Currently, 63% of Coinbase users are buying Enzyme. In other words, 63% of Coinbase customers have increased their net position in Enzyme over the past 24 hours through trading.

Yes, Enzyme is currently available on Coinbase’s centralized exchange. For more detailed instructions, check out our helpful how to buy Enzyme guide.